Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Short term Debt (2022 - 2025)

Cryo Cell International (CCEL) has disclosed Short term Debt for 4 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Short term Debt fell 34.66% to $2.3 million in Q4 2025 year-over-year; TTM through Nov 2025 was $2.3 million, a 34.66% decrease, with the full-year FY2025 number at $2.3 million, down 34.66% from a year prior.
  • Short term Debt was $2.3 million for Q4 2025 at Cryo Cell International, down from $3.2 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $6.6 million in Q2 2025 to a low of $1.2 million in Q4 2023.
  • A 4-year average of $3.0 million and a median of $2.3 million in 2025 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: tumbled 46.2% in 2023, then soared 187.88% in 2024.
  • Cryo Cell International's Short term Debt stood at $2.3 million in 2022, then crashed by 46.2% to $1.2 million in 2023, then skyrocketed by 187.88% to $3.5 million in 2024, then plummeted by 34.66% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Short term Debt are $2.3 million (Q4 2025), $3.2 million (Q3 2025), and $6.6 million (Q2 2025).